About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02248584

VITAMIN E, C and ZINC IN PATIENTS WITH SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE

The objective of this study was to evaluate the effects of supplementary antioxidant therapy on the levels of biomarkers and inflamatory citocines in patients with a previous history of non-melanoma s...

Lead sponsor: University of Campinas, Brazil•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Campinas, Brazil

Age

20 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•patients who had non-melanoma skin cancer (squamous cell carcinoma or basal cell carcinoma) and who were treated with surgery
•age ≥20 years
•absence of comorbidities such as type 1 diabetes, severe heart disease, hepatic dysfunction, renal failure requiring dialysis, HIV infection, and melanoma skin cancer
•no history of chemotherapy or radiotherapy in the previous 6 months
•absence of severe psychiatric disease that limited comprehension
•not taking any vitamin and/or mineral supplementation.

Exclusion Criteria

•subjects did not complete the entire course of supplemental therapy.

Related studies

The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery

NCT07524062 · Wound Healing, Surgical Wound Infection, and more

Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma

NCT07404605 · MELANOMA, SKIN NEOPLASMS

Active Not Recruiting

M7824 Related Adverse Effects in Adults With Cancer

NCT04267861 · Neoplasms, Skin Neoplasms

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

NCT00001813 · Cockayne Syndrome, Skin Neoplasms, and more

COMPLETEDPhase 2/3

A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)

NCT06295809 · Carcinoma, Squamous Cell, Skin Neoplasms

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 25, 2014Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment60

Start dateJan 2011

Last updatedSep 25, 2014

Condition

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 25, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions